Personal information

United States

Activities

Employment (1)

Center for Disease Analysis Foundation: Lafayette, Colorado, US

2017-12-01 to present | Managing Director
Employment
Source: Self-asserted source
Homie Razavi

Works (50 of 161)

Items per page:
Page 1 of 4

Number of people treated for hepatitis C virus infection in 2014-2023 and applicable lessons for new HBV and HDV therapies

Journal of Hepatology
2025-02 | Journal article
Contributors: Homie A. Razavi; Imam Waked; Huma Qureshi; Loreta A. Kondili; Ann-Sofi Duberg; Soo Aleman; Junko Tanaka; Jeffrey V. Lazarus; Daniel Low-Beer; Zaigham Abbas et al.
Source: check_circle
Crossref

Modeling the Health and Economic Impact of Pharmacologic Therapies for MASLD in the United States

Journal of Hepatology
2025-01 | Journal article
Contributors: Carolyn Wallace; Ivane Gamkrelidze; Chris Estes; Homie Razavi; Arun J. Sanyal
Source: check_circle
Crossref

Adjusted estimate of the prevalence of hepatitis delta virus in 25 countries and territories

Journal of Hepatology
2024 | Journal article
EID:

2-s2.0-85181735099

Part of ISSN: 16000641 01688278
Contributors: Razavi-Shearer, D.; Child, H.; Razavi-Shearer, K.; Voeller, A.; Razavi, H.; Buti, M.; Tacke, F.; Terrault, N.; Zeuzem, S.; Abbas, Z. et al.
Source: Self-asserted source
Homie Razavi via Scopus - Elsevier

Assessing the hepatitis C epidemiology in Switzerland: It’s not that trivial

Journal of Viral Hepatitis
2024 | Journal article
EID:

2-s2.0-85181078977

Part of ISSN: 13652893 13520504
Contributors: Blach, S.; Bregenzer, A.; Bruggmann, P.; Cerny, A.; Maeschli, B.; Müllhaupt, B.; Negro, F.; Razavi, H.; Scheidegger, C.; Semela, D.
Source: Self-asserted source
Homie Razavi via Scopus - Elsevier

Response to “Reply to ‘Assessing the hepatitis C epidemiology in Switzerland: It’s not that trivial’”

Journal of Viral Hepatitis
2024 | Journal article
EID:

2-s2.0-85166909508

Part of ISSN: 13652893 13520504
Contributors: Razavi, H.; Blach, S.; Bregenzer, A.; Bruggmann, P.; Cerny, A.; Maeschli, B.; Müllhaupt, B.; Negro, F.; Scheidegger, C.; Semela, D.
Source: Self-asserted source
Homie Razavi via Scopus - Elsevier

Cost-effectiveness and economic investment to eliminate chronic hepatitis C in Mexico

Journal of Viral Hepatitis
2023 | Journal article
EID:

2-s2.0-85152019022

Part of ISSN: 13652893 13520504
Contributors: Mooneyhan, E.; De la Torre Rosas, A.; Serrano, D.B.; Gamkrelidze, I.; Sanchez, M.J.; Kershenobich, D.; Sereno, L.; Razavi, H.
Source: Self-asserted source
Homie Razavi via Scopus - Elsevier

Cost-effectiveness modelling of birth and infant dose vaccination against hepatitis B virus in Ontario from 2020 to 2050

CMAJ open
2023 | Journal article
EID:

2-s2.0-85146103383

Part of ISSN: 22910026
Contributors: Biondi, M.J.; Estes, C.; Razavi-Shearer, D.; Sahdra, K.; Lipton, N.; Shah, H.; Capraru, C.; Janssen, H.L.A.; Razavi, H.; Feld, J.J.
Source: Self-asserted source
Homie Razavi via Scopus - Elsevier

Cost-effectiveness of treating all hepatitis B–positive individuals in the United States

Journal of Viral Hepatitis
2023 | Journal article
EID:

2-s2.0-85161418509

Part of ISSN: 13652893 13520504
Contributors: Razavi-Shearer, D.; Estes, C.; Gamkrelidze, I.; Razavi, H.
Source: Self-asserted source
Homie Razavi via Scopus - Elsevier

Enhancing interventions for prevention of mother-to-child- transmission of hepatitis B virus

JHEP Reports
2023 | Journal article
EID:

2-s2.0-85164398621

Part of ISSN: 25895559
Contributors: Matthews, P.C.; Ocama, P.; Wang, S.; El-Sayed, M.; Turkova, A.; Ford, D.; Torimiro, J.; Garcia Ferreira, A.C.; Espinosa Miranda, A.; De La Hoz Restrepo, F.P. et al.
Source: Self-asserted source
Homie Razavi via Scopus - Elsevier

Evidence for Benefits of Early Treatment Initiation for Chronic Hepatitis B

Viruses
2023 | Journal article
EID:

2-s2.0-85156219579

Part of ISSN: 19994915
Contributors: Lim, Y.-S.; Kim, W.R.; Dieterich, D.; Kao, J.-H.; Flaherty, J.F.; Yee, L.J.; Roberts, L.R.; Razavi, H.; Kennedy, P.T.F.
Source: Self-asserted source
Homie Razavi via Scopus - Elsevier
grade
Preferred source (of 3)‎

Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study

The Lancet Gastroenterology and Hepatology
2023 | Journal article
EID:

2-s2.0-85169786860

Part of ISSN: 24681253
Contributors: Razavi-Shearer, D.M.; Gamkrelidze, I.; Pan, C.Q.; Jia, J.; Berg, T.; Gray, R.T.; Lim, Y.-S.; Chen, C.-J.; Ocama, P.; Desalegn, H. et al.
Source: Self-asserted source
Homie Razavi via Scopus - Elsevier

Global reporting of progress towards elimination of hepatitis B and hepatitis C

The Lancet Gastroenterology and Hepatology
2023 | Journal article
EID:

2-s2.0-85148726032

Part of ISSN: 24681253
Contributors: Cui, F.; Blach, S.; Manzengo Mingiedi, C.; Gonzalez, M.A.; Sabry Alaama, A.; Mozalevskis, A.; Séguy, N.; Rewari, B.B.; Chan, P.-L.; Le, L.-V. et al.
Source: Self-asserted source
Homie Razavi via Scopus - Elsevier

Hepatitis C prevalence and elimination planning in Pakistan, a bottom-up approach accounting for provincial variation

Journal of Viral Hepatitis
2023 | Journal article
EID:

2-s2.0-85147414453

Part of ISSN: 13652893 13520504
Contributors: Mooneyhan, E.; Qureshi, H.; Mahmood, H.; Tariq, M.; Maqbool, N.A.; Anwar, M.; Aslam, M.; Azam, F.; Blach, S.; Khan, A.G. et al.
Source: Self-asserted source
Homie Razavi via Scopus - Elsevier

Hepatitis D double reflex testing of all hepatitis B carriers in low-HBV- and high-HBV/HDV-prevalence countries

Journal of Hepatology
2023 | Journal article
EID:

2-s2.0-85159287431

Part of ISSN: 16000641 01688278
Contributors: Razavi, H.A.; Buti, M.; Terrault, N.A.; Zeuzem, S.; Yurdaydin, C.; Tanaka, J.; Aghemo, A.; Akarca, U.S.; Al Masri, N.M.; Alalwan, A.M. et al.
Source: Self-asserted source
Homie Razavi via Scopus - Elsevier
grade
Preferred source (of 2)‎

Impacts of the Egyptian national screening and treatment programme for viral hepatitis C: A cost-effectiveness model

Liver International
2023 | Journal article
EID:

2-s2.0-85153335110

Part of ISSN: 14783231 14783223
Contributors: Ezzat, S.; Gamkrelidze, I.; Osman, A.; Gomaa, A.; Roushdy, A.; Esmat, G.; Razavi, H.; Blach, S.; Abdel-Razek, W.; El-Akel, W. et al.
Source: Self-asserted source
Homie Razavi via Scopus - Elsevier
grade
Preferred source (of 2)‎

Modeling HCV elimination recovery following the COVID-19 pandemic in the United States: Pathways to regain progress

Journal of Infection and Public Health
2023 | Journal article
EID:

2-s2.0-85143615194

Part of ISSN: 1876035X 18760341
Contributors: Blach, S.; Brown, K.A.; Brown, R.S.; Gholam, P.M.; Terrault, N.A.; Estes, C.; Razavi, H.A.
Source: Self-asserted source
Homie Razavi via Scopus - Elsevier

Reply to: “Does currently recommended maternal antiviral prophylaxis against mother-to-child transmission of hepatitis B virus require enhancement?”

JHEP Reports
2023 | Journal article
EID:

2-s2.0-85173155122

Part of ISSN: 25895559
Contributors: Matthews, P.C.; Ocama, P.; Wang, S.; El-Sayed, M.; Turkova, A.; Ford, D.; Torimiro, J.; Garcia Ferreira, A.C.; Miranda, A.E.; De La Hoz Restrepo, F.P. et al.
Source: Self-asserted source
Homie Razavi via Scopus - Elsevier

Response to overcoming the challenges in eliminating viral hepatitis in low- and middle-income countries

Liver International
2023 | Journal article
EID:

2-s2.0-85162643222

Part of ISSN: 14783231 14783223
Contributors: Razavi, H.
Source: Self-asserted source
Homie Razavi via Scopus - Elsevier
grade
Preferred source (of 2)‎

Securing wider EU commitment to the elimination of hepatitis C virus

Liver International
2023 | Journal article
EID:

2-s2.0-85144100419

Part of ISSN: 14783231 14783223
Contributors: Wedemeyer, H.; Tergast, T.L.; Lazarus, J.V.; Razavi, H.; Bakoyannis, K.; Baptista-Leite, R.; Bartoli, M.; Bruggmann, P.; Buşoi, C.-S.; Buti, M. et al.
Source: Self-asserted source
Homie Razavi via Scopus - Elsevier

The current and future burden of hepatitis B in Switzerland: a modelling study

Swiss Medical Weekly
2023 | Journal article
EID:

2-s2.0-85162222348

Part of ISSN: 14243997 14247860
Contributors: Negro, F.; Mullhaupt, B.; Semela, D.; Blach, S.; Bruggmann, P.; De Gottardi, A.; Dufour, J.-F.; Fraga, M.; Galante, A.; Razavi, H. et al.
Source: Self-asserted source
Homie Razavi via Scopus - Elsevier

The impact of immigration on hepatitis B burden in the United States: a modelling study

The Lancet Regional Health - Americas
2023 | Journal article
EID:

2-s2.0-85160328867

Part of ISSN: 2667193X
Contributors: Razavi-Shearer, D.; Gamkrelidze, I.; Pan, C.Q.; Razavi-Shearer, K.; Blach, S.; Estes, C.; Mooneyhan, E.; Razavi, H.
Source: Self-asserted source
Homie Razavi via Scopus - Elsevier
grade
Preferred source (of 2)‎

Viral hepatitis elimination challenges in low- and middle-income countries—Uzbekistan Hepatitis Elimination Program (UHEP)

Liver International
2023 | Journal article
EID:

2-s2.0-85146449160

Part of ISSN: 14783231 14783223
Contributors: Musabaev, E.; Estes, C.; Sadirova, S.; Bakieva, S.; Brigida, K.; Dunn, R.; Kottilil, S.; Mathur, P.; Abutaleb, A.; Razavi-Shearer, K. et al.
Source: Self-asserted source
Homie Razavi via Scopus - Elsevier

Advancing the global public health agenda for NAFLD: a consensus statement

Nature Reviews Gastroenterology and Hepatology
2022 | Journal article
EID:

2-s2.0-85117913817

Part of ISSN: 17595053 17595045
Contributors: Lazarus, J.V.; Mark, H.E.; Anstee, Q.M.; Arab, J.P.; Batterham, R.L.; Castera, L.; Cortez-Pinto, H.; Crespo, J.; Cusi, K.; Dirac, M.A. et al.
Source: Self-asserted source
Homie Razavi via Scopus - Elsevier

Epidemiology, Natural History, and Outcomes of Primary Sclerosing Cholangitis: A Systematic Review of Population-based Studies

Clinical Gastroenterology and Hepatology
2022 | Journal article
EID:

2-s2.0-85119416409

Part of ISSN: 15427714 15423565
Contributors: Trivedi, P.J.; Bowlus, C.L.; Yimam, K.K.; Razavi, H.; Estes, C.
Source: Self-asserted source
Homie Razavi via Scopus - Elsevier

Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study

The Lancet Gastroenterology and Hepatology
2022 | Journal article
EID:

2-s2.0-85128487734

Part of ISSN: 24681253
Contributors: Blach, S.; Terrault, N.A.; Tacke, F.; Gamkrelidze, I.; Craxi, A.; Tanaka, J.; Waked, I.; Dore, G.J.; Abbas, Z.; Abdallah, A.R. et al.
Source: Self-asserted source
Homie Razavi via Scopus - Elsevier

HCV disease burden and population segments in Switzerland

Liver International
2022 | Journal article
EID:

2-s2.0-85120889647

Part of ISSN: 14783231 14783223
Contributors: Bihl, F.; Bruggmann, P.; Castro Batänjer, E.; Dufour, J.-F.; Lavanchy, D.; Müllhaupt, B.; Negro, F.; Razavi, H.; Scheidegger, C.; Semela, D. et al.
Source: Self-asserted source
Homie Razavi via Scopus - Elsevier

Impact of expanding hepatitis B treatment guidelines: A modelling and economic impact analysis

Alimentary Pharmacology and Therapeutics
2022 | Journal article
EID:

2-s2.0-85130576230

Part of ISSN: 13652036 02692813
Contributors: Lim, Y.-S.; Ahn, S.H.; Shim, J.-J.; Razavi, H.; Razavi-Shearer, D.; Sinn, D.H.
Source: Self-asserted source
Homie Razavi via Scopus - Elsevier

Opportunistic co-screening for HCV and COVID-19-related services: A creative response with a need for thoughtful reflection

Liver International
2022 | Journal article
EID:

2-s2.0-85128448717

Part of ISSN: 14783231 14783223
Contributors: Kondili, L.A.; Craxì, L.; Andreoni, M.; Mennini, F.S.; Razavi, H.
Source: Self-asserted source
Homie Razavi via Scopus - Elsevier

Polaris Observatory—supporting informed decision-making at the national, regional, and global levels to eliminate viral hepatitis

Antiviral Therapy
2022 | Journal article
EID:

2-s2.0-85126585089

Part of ISSN: 20402058 13596535
Contributors: Razavi, H.
Source: Self-asserted source
Homie Razavi via Scopus - Elsevier
grade
Preferred source (of 2)‎

Progress towards achieving viral hepatitis B and C elimination in the Asia and Pacific region: Results from modelling and global reporting

Liver International
2022 | Journal article
EID:

2-s2.0-85121758133

Part of ISSN: 14783231 14783223
Contributors: Le, L.-V.; Blach, S.; Rewari, B.; Chan, P.; Fuqiang, C.; Ishikawa, N.; Sharma, M.; Mangadan-Konath, N.; Razavi, H.; Low-Beer, D. et al.
Source: Self-asserted source
Homie Razavi via Scopus - Elsevier

Ten years countdown to hepatitis C elimination in Belgium: a mathematical modeling approach

BMC Infectious Diseases
2022 | Journal article
EID:

2-s2.0-85128760235

Part of ISSN: 14712334
Contributors: Busschots, D.; Ho, E.; Blach, S.; Nevens, F.; Razavi, H.; Van Damme, B.; Vanwolleghem, T.; Robaeys, G.
Source: Self-asserted source
Homie Razavi via Scopus - Elsevier

The global NAFLD policy review and preparedness index: Are countries ready to address this silent public health challenge?

Journal of Hepatology
2022 | Journal article
EID:

2-s2.0-85122443139

Part of ISSN: 16000641 01688278
Contributors: Lazarus, J.V.; Mark, H.E.; Villota-Rivas, M.; Palayew, A.; Carrieri, P.; Colombo, M.; Ekstedt, M.; Esmat, G.; George, J.; Marchesini, G. et al.
Source: Self-asserted source
Homie Razavi via Scopus - Elsevier

The Payer License Agreement, or “Netflix model,” for hepatitis C virus therapies enables universal treatment access, lowers costs and incentivizes innovation and competition

Liver International
2022 | Journal article
EID:

2-s2.0-85127245138

Part of ISSN: 14783231 14783223
Contributors: Matthews, D.W.; Coleman, S.; Razavi, H.; Izaret, J.-M.
Source: Self-asserted source
Homie Razavi via Scopus - Elsevier
grade
Preferred source (of 2)‎

Updated epidemiology of hepatitis C virus infections and implications for hepatitis C virus elimination in Germany

Journal of Viral Hepatitis
2022 | Journal article
EID:

2-s2.0-85129385927

Part of ISSN: 13652893 13520504
Contributors: Tergast, T.L.; Blach, S.; Tacke, F.; Berg, T.; Cornberg, M.; Kautz, A.; Manns, M.; Razavi, H.; Sarrazin, C.; Serfert, Y. et al.
Source: Self-asserted source
Homie Razavi via Scopus - Elsevier

Estimating the health impact of vaccination against ten pathogens in 98 low-income and middle-income countries from 2000 to 2030: a modelling study

The Lancet
2021 | Journal article
EID:

2-s2.0-85099820899

Part of ISSN: 1474547X 01406736
Contributors: Li, X.; Mukandavire, C.; Cucunubá, Z.M.; Echeverria Londono, S.; Abbas, K.; Clapham, H.E.; Jit, M.; Johnson, H.L.; Papadopoulos, T.; Vynnycky, E. et al.
Source: Self-asserted source
Homie Razavi via Scopus - Elsevier

Global prevalence of hepatitis C virus in women of childbearing age in 2019: a modelling study

The Lancet Gastroenterology and Hepatology
2021 | Journal article
EID:

2-s2.0-85100656437

Part of ISSN: 24681253
Contributors: Dugan, E.; Blach, S.; Biondi, M.; Cai, Z.; DePaola, M.; Estes, C.; Feld, J.; Gamkrelidze, I.; Kottilil, S.; Ma, S. et al.
Source: Self-asserted source
Homie Razavi via Scopus - Elsevier

Hepatitis C elimination in Sweden: Progress, challenges and opportunities for growth in the time of COVID-19

Liver International
2021 | Journal article
EID:

2-s2.0-85108903498

Part of ISSN: 14783231 14783223
Contributors: Blach, S.; Blomé, M.; Duberg, A.-S.; Jerkeman, A.; Kåberg, M.; Klasa, P.-E.; Lagging, M.; Razavi-Shearer, D.; Razavi, H.; Aleman, S.
Source: Self-asserted source
Homie Razavi via Scopus - Elsevier

Impact of COVID-19 on global HCV elimination efforts

Journal of Hepatology
2021 | Journal article
EID:

2-s2.0-85095814984

Part of ISSN: 16000641 01688278
Contributors: Blach, S.; Kondili, L.A.; Aghemo, A.; Cai, Z.; Dugan, E.; Estes, C.; Gamkrelidze, I.; Ma, S.; Pawlotsky, J.-M.; Razavi-Shearer, D. et al.
Source: Self-asserted source
Homie Razavi via Scopus - Elsevier

Lives saved with vaccination for 10 pathogens across 112 countries in a pre-covid-19 world

eLife
2021 | Journal article
EID:

2-s2.0-85111440265

Part of ISSN: 2050084X
Contributors: Toor, J.; Echeverria-Londono, S.; Li, X.; Abbas, K.; Carter, E.D.; Clapham, H.E.; Clark, A.; de Villiers, M.J.; Eilertson, K.; Ferrari, M. et al.
Source: Self-asserted source
Homie Razavi via Scopus - Elsevier

Progress towards hepatitis C virus elimination in high-income countries: An updated analysis

Liver International
2021 | Journal article
EID:

2-s2.0-85100117888

Part of ISSN: 14783231 14783223
Contributors: Gamkrelidze, I.; Pawlotsky, J.-M.; Lazarus, J.V.; Feld, J.J.; Zeuzem, S.; Bao, Y.; Gabriela Pires dos Santos, A.; Sanchez Gonzalez, Y.; Razavi, H.
Source: Self-asserted source
Homie Razavi via Scopus - Elsevier
grade
Preferred source (of 2)‎

The case for simplifying and using absolute targets for viral hepatitis elimination goals

Journal of Viral Hepatitis
2021 | Journal article
EID:

2-s2.0-85098674981

Part of ISSN: 13652893 13520504
Contributors: Razavi, H.; Blach, S.; Razavi-Shearer, D.; Abaalkhail, F.; Abbas, Z.; Abdallah, A.; Abrao Ferreira, P.; Abu Raddad, L.J.; Adda, D.; Agarwal, K. et al.
Source: Self-asserted source
Homie Razavi via Scopus - Elsevier
grade
Preferred source (of 2)‎

The cost-effectiveness of hepatitis C virus elimination in low- and middle-income countries

Journal of Viral Hepatitis
2021 | Journal article
EID:

2-s2.0-85096893589

Part of ISSN: 13652893 13520504
Contributors: Razavi, H.
Source: Self-asserted source
Homie Razavi via Scopus - Elsevier
grade
Preferred source (of 2)‎

A micro-elimination approach to addressing hepatitis C in Turkey

BMC Health Services Research
2020 | Journal article
EID:

2-s2.0-85082380222

Part of ISBN:

14726963

Contributors: Idilman, R.; Razavi, H.; Robbins-Scott, S.; Akarca, U.S.; Örmeci, N.; Kaymakoglu, S.; Aygen, B.; Tozun, N.; Güner, R.; Bodur, H. et al.
Source: Self-asserted source
Homie Razavi via Scopus - Elsevier

A tool to measure the economic impact of Hepatitis B elimination: A case study in Saudi Arabia

Journal of Infection and Public Health
2020 | Journal article
EID:

2-s2.0-85091878706

Part of ISSN: 1876035X 18760341
Contributors: Sanai, F.M.; Alghamdi, M.; Dugan, E.; Alalwan, A.; Al-Hamoudi, W.; Abaalkhail, F.; AlMasri, N.; Razavi-Shearer, D.; Razavi, H.; Schmelzer, J. et al.
Source: Self-asserted source
Homie Razavi via Scopus - Elsevier

A tool to measure the impact of inaction toward elimination of hepatitis C: A case study in Korea

PLoS ONE
2020 | Journal article
EID:

2-s2.0-85083918622

Part of ISBN:

19326203

Contributors: Won, Y.K.; Kang, K.S.; Gonzalez, Y.S.; Razavi, H.; Dugan, E.; Han, K.-H.; Ahn, S.H.; Jeon, M.Y.; Kim, D.Y.
Source: Self-asserted source
Homie Razavi via Scopus - Elsevier

Assessment of Treatment Strategies to Achieve Hepatitis C Elimination in Canada Using a Validated Model

JAMA network open
2020 | Journal article
EID:

2-s2.0-85084380059

Part of ISBN:

25743805

Contributors: Binka, M.; Janjua, N.Z.; Grebely, J.; Estes, C.; Schanzer, D.; Kwon, J.A.; Shoukry, N.H.; Kwong, J.C.; Razavi, H.; Feld, J.J. et al.
Source: Self-asserted source
Homie Razavi via Scopus - Elsevier

Burden of nonalcoholic fatty liver disease in Canada, 2019-2030: a modelling study

CMAJ open
2020 | Journal article
EID:

2-s2.0-85097430865

Part of ISSN: 22910026
Contributors: Swain, M.G.; Ramji, A.; Patel, K.; Sebastiani, G.; Shaheen, A.A.; Tam, E.; Marotta, P.; Elkhashab, M.; Bajaj, H.S.; Estes, C. et al.
Source: Self-asserted source
Homie Razavi via Scopus - Elsevier

Do the most heavily burdened countries have the right policies to eliminate viral hepatitis B and C?

The Lancet Gastroenterology and Hepatology
2020 | Journal article
EID:

2-s2.0-85089371784

Part of ISSN: 24681253
Contributors: Palayew, A.; Razavi, H.; Hutchinson, S.J.; Cooke, G.S.; Lazarus, J.V.
Source: Self-asserted source
Homie Razavi via Scopus - Elsevier

Editorial: increasing burden of nonalcoholic fatty liver disease—a call to action. Authors' reply

Alimentary Pharmacology and Therapeutics
2020 | Journal article
EID:

2-s2.0-85085187393

Part of ISBN:

13652036 02692813

Contributors: Estes, C.; Chan, H.L.Y.; Chien, R.N.; Chuang, W.-L.; Fung, J.; Goh, G.B.-B.; Hu, T.H.; Huang, J.-F.; Jang, B.K.; Jun, D.W. et al.
Source: Self-asserted source
Homie Razavi via Scopus - Elsevier

Global Epidemiology of Viral Hepatitis

Gastroenterology clinics of North America
2020 | Journal article
EID:

2-s2.0-85084399495

Part of ISBN:

15581942

Contributors: Razavi, H.
Source: Self-asserted source
Homie Razavi via Scopus - Elsevier
Items per page:
Page 1 of 4

Peer review (2 reviews for 2 publications/grants)

Review activity for Journal of hepatology. (1)
Review activity for The Lancet. (1)